INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00850

Transcatheter aortic valve-in-valve treatment in prior Sorin Freedom Solo valve

Mohammed Shamim Rahman*, MBBS, BSc (Hons), MRCP; James Cockburn, MBBS, BSc (Hons), MRCP, MD; Uday Trivedi, BSc (Hons), MBBS, FRCS(C-Th), FECTS; David Hildick-Smith, MD, FRCP, FSCAI

Valve-in-valve interventions in Freedom Solo™ valves (Sorin Group [now LivaNova], Milan, Italy) are high risk due to the supra-annular stentless design, with long leaflets potentially jeopardising the coronary ostia1,2.

Three years previously, an 83-year-old lady had a 26 mm CoreValve® (Medtronic, Minneapolis, MN, USA) implanted inside a stenosed 23 mm Freedom Solo valve (the 23 mm CoreValve was then unavailable). Preliminary balloon valvuloplasty was performed with contrast aortography, confirming good coronary flow. A guide catheter was placed in the left main stem as a precaution. On deployment of the valve, however, the right coronary artery immediately occluded. The left coronary appeared to have good flow and was not stented but occluded upon guide withdrawal. The valve was therefore snared into the ascending aorta under conditions of cardiac arrest, relieving coronary obstruction (Panel A, Panel B). The patient improved significantly following this procedure.

Aged 86, she developed severe symptomatic valvular restenosis (peak gradient 80 mmHg, AVA 0.70 cm2, STS score 7.2) so we reluctantly agreed to re-attempt TAVI.

Right femoral artery access was achieved with a 14 Fr sheath. Cine and fluoroscopic image captures revealed the previous TAVI deployed in the ascending aorta (Panel B, Panel C). Both coronary ostia were simultaneously engaged (EBU3.5 for LCA, JR4 guide for RCA, Runthrough® floppy wires [Terumo Corp., Tokyo, Japan] to both) (Panel C, Panel D). 3.5x18 mm and 4x20 mm Resolute Onyx™ stents (Medtronic) were positioned in readiness in the RCA and LCA ostia, respectively (Panel E). A 23 mm Evolut™ (Medtronic) was taken around the aortic arch over a Safari™ wire (Boston Scientific, Marlborough, MA, USA), without the need for snaring the previous valve (Panel E). The CoreValve was incrementally deployed in a good position just below the Freedom Solo neoannulus (Panel F, Panel G) with serial contrast injections performed to confirm coronary artery patency. Through staged valve release, the LMS (Panel F) and RCA (Panel G) were stented with marginal overhang into the aorta. Once the valve was fully released, both stents were post-dilated to ensure no stent crush from the second TAVI. On this occasion, coronary flow was maintained following full valve release and guide catheter withdrawal (Panel H).

Practical implications

This represented a successful TAVI implant with no transvalvular/paravalvular leak of note by fluoroscopy or transthoracic echocardiography. The patient was discharged on warfarin (for atrial fibrillation [AF]), clopidogrel 75 mg OD for two weeks and aspirin 75 mg OD for life and remains clinically well at six-month follow-up. Careful planning of procedural strategy may help obviate potential complications when performing valve-in-valve interventions. Whilst this “chimney” stenting technique successfully protected the coronary ostia, this requires further scrutiny and should only be employed where no other viable options exist.

Conflict of interest statement

D. Hildick-Smith is a proctor for Medtronic. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Redo TAVI into failing Freedom Solo valve.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Redo TAVI into failing Freedom Solo valve.

Volume 14 Number 3
Jun 14, 2018
Volume 14 Number 3
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-21-01004 Jul 22, 2022
Chimney kissing stenting after transcatheter aortic valve implantation
Kalogeropoulos A et al
free

Flashlight

10.4244/EIJ-D-23-00927 Jun 3, 2024
Chimney/snorkel stenting during TAV-in-TAV: bedside to bench
Brown CL et al

10.4244/EIJV16I12A176 Dec 18, 2020
Coronary re-access after redo TAVI: a proposed classification to simplify evaluation
Tang GH and Zaid S
free

Clinical research

10.4244/EIJ-D-22-01125 Jul 17, 2023
Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy
Grubb KJ et al
free

Short report

10.4244/EIJ-D-19-01094 Jun 12, 2020
TAVR-in-TAVR and coronary access: importance of preprocedural planning
Tarantini G et al
free

Image – Interventional flashlight

10.4244/EIJ-D-22-00385 Jan 23, 2023
Double chimney stenting without contrast during transcatheter aortic valve-in-valve implantation
Armario X et al
free

10.4244/EIJV16I2A15 Jun 12, 2020
TAV-in-TAV for failed prosthesis: the new frontier
Tchétché D and Siddiqui S
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved